Browsing Tag
Neurophet
1 post
Neurophet bags third FDA 510(k) clearance as AI imaging tools move closer to frontline Alzheimer’s care decisions
Neurophet wins FDA clearance for AQUA AD Plus, strengthening its U.S. strategy as AI imaging becomes central to Alzheimer’s treatment decisions. Read more.